Anti-GPR26 monoclonal antibody

Anti-GPR26 antibody for FACS & in-vivo assay

Target products collectionGo to GPR26/GPR26 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP0530-Ab-1/ GM-Tg-hg-MP0530-Ab-2Anti-Human GPR26 monoclonal antibodyHuman
GM-Tg-rg-MP0530-Ab-1/ GM-Tg-rg-MP0530-Ab-2Anti-Rat GPR26 monoclonal antibodyRat
GM-Tg-mg-MP0530-Ab-1/ GM-Tg-mg-MP0530-Ab-2Anti-Mouse GPR26 monoclonal antibodyMouse
GM-Tg-cynog-MP0530-Ab-1/ GM-Tg-cynog-MP0530-Ab-2Anti-Cynomolgus/ Rhesus macaque GPR26 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP0530-Ab-1/ GM-Tg-felg-MP0530-Ab-2Anti-Feline GPR26 monoclonal antibodyFeline
GM-Tg-cang-MP0530-Ab-1/ GM-Tg-cang-MP0530-Ab-2Anti-Canine GPR26 monoclonal antibodyCanine
GM-Tg-bovg-MP0530-Ab-1/ GM-Tg-bovg-MP0530-Ab-2Anti-Bovine GPR26 monoclonal antibodyBovine
GM-Tg-equg-MP0530-Ab-1/ GM-Tg-equg-MP0530-Ab-2Anti-Equine GPR26 monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP0530-Ab-1/ GM-Tg-hg-MP0530-Ab-2; GM-Tg-rg-MP0530-Ab-1/ GM-Tg-rg-MP0530-Ab-2;
GM-Tg-mg-MP0530-Ab-1/ GM-Tg-mg-MP0530-Ab-2; GM-Tg-cynog-MP0530-Ab-1/ GM-Tg-cynog-MP0530-Ab-2;
GM-Tg-felg-MP0530-Ab-1/ GM-Tg-felg-MP0530-Ab-2; GM-Tg-cang-MP0530-Ab-1/ GM-Tg-cang-MP0530-Ab-2;
GM-Tg-bovg-MP0530-Ab-1/ GM-Tg-bovg-MP0530-Ab-2; GM-Tg-equg-MP0530-Ab-1/ GM-Tg-equg-MP0530-Ab-2
Products NameAnti-GPR26 monoclonal antibody
Formatmab
Target NameGPR26
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-GPR26 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species GPR26 VLP (virus-like particle) (Products Developing)


    Target information

    Target IDGM-MP0530
    Target NameGPR26
    Gene ID2849,233919,192153,693327,486926,101097672,617411,100057676
    Gene Symbol and Synonyms9630036A11Rik,A730021D22,GPR26
    Uniprot AccessionQ8NDV2,Q9QXI3
    Uniprot Entry NameGPR26_HUMAN,GPR26_RAT
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000154478
    Target ClassificationGPCR

    The target: GPR26, gene name: GPR26, also named as . This gene encodes a G protein-couple receptor protein. G-protein-coupled receptors are a large family of membrane proteins that are involved in cellular responses to environmental stimuli, neurotransmitters, and hormones. The encoded protein may play a role in neurodegenerative diseases. Epigenetic silencing of this gene has been observed in gliomas. [provided by RefSeq, Sep 2016].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.